WO2001051659A3 - Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders - Google Patents
Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders Download PDFInfo
- Publication number
- WO2001051659A3 WO2001051659A3 PCT/IB2001/000116 IB0100116W WO0151659A3 WO 2001051659 A3 WO2001051659 A3 WO 2001051659A3 IB 0100116 W IB0100116 W IB 0100116W WO 0151659 A3 WO0151659 A3 WO 0151659A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biallelic markers
- genes involved
- genomic regions
- nervous system
- central nervous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002395240A CA2395240A1 (en) | 2000-01-13 | 2001-01-11 | Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders |
EP01901330A EP1285088A2 (en) | 2000-01-13 | 2001-01-11 | Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders |
AU26999/01A AU2699901A (en) | 2000-01-13 | 2001-01-11 | Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17585400P | 2000-01-13 | 2000-01-13 | |
US60/175,854 | 2000-01-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001051659A2 WO2001051659A2 (en) | 2001-07-19 |
WO2001051659A3 true WO2001051659A3 (en) | 2002-12-05 |
Family
ID=22641928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2001/000116 WO2001051659A2 (en) | 2000-01-13 | 2001-01-11 | Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1285088A2 (en) |
AU (1) | AU2699901A (en) |
CA (1) | CA2395240A1 (en) |
WO (1) | WO2001051659A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2401749A1 (en) | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
US20060088835A1 (en) * | 2002-04-05 | 2006-04-27 | Pickard Benjamin S | Schizophrenia associated genes |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
US7927840B2 (en) | 2006-09-11 | 2011-04-19 | Gen Probe Incorporated | Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region |
EP2977470B1 (en) | 2002-10-16 | 2018-01-03 | Gen-Probe Incorporated | Compositions and methods for detecting west nile virus |
US20090291432A1 (en) * | 2004-06-01 | 2009-11-26 | Queensland University Of Technology | Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene |
AU2006246116A1 (en) * | 2005-05-11 | 2006-11-16 | Aarhus Universitet | Method for diagnosis and treatment of a mental disease |
KR100818275B1 (en) * | 2006-09-26 | 2008-03-31 | 삼성전자주식회사 | Primer set for amplifying target sequences of Norovirus probe set specifically hybridizable with the target sequences of Norovirus microarray having the immobilized probe set and method for detecting the presence of Norovirus using the probe set |
WO2008086579A1 (en) * | 2007-01-19 | 2008-07-24 | Queensland University Of Technology | Diagnostic methods and agents |
EP2897608B1 (en) * | 2013-04-22 | 2018-08-22 | InnoBioscience, LLC | Treatment of alzheimer's and cognitive impairment with andrographolides |
ES2917181T3 (en) * | 2015-07-10 | 2022-07-07 | Ionis Pharmaceuticals Inc | Diacylglycerol acyltransferase 2 (DGAT2) modulators |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054500A2 (en) * | 1998-04-21 | 1999-10-28 | Genset | Biallelic markers for use in constructing a high density disequilibrium map of the human genome |
-
2001
- 2001-01-11 WO PCT/IB2001/000116 patent/WO2001051659A2/en active Application Filing
- 2001-01-11 CA CA002395240A patent/CA2395240A1/en not_active Abandoned
- 2001-01-11 AU AU26999/01A patent/AU2699901A/en not_active Abandoned
- 2001-01-11 EP EP01901330A patent/EP1285088A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054500A2 (en) * | 1998-04-21 | 1999-10-28 | Genset | Biallelic markers for use in constructing a high density disequilibrium map of the human genome |
Non-Patent Citations (7)
Title |
---|
CHEN Y S ET AL.: "A single nucleotide polymorphism map of a bipolar disorder candidate region on chromosome 18q21.3-22.1", THE AMERICAN JOURNAL OF HUMAN GENETICS, vol. 65, no. 4, October 1999 (1999-10-01), pages A245, XP008001465 * |
DATABASE EMBL european molecular biology laboratory; 15 March 1999 (1999-03-15), ZHAO S ET AL.: "Use of BAC end sequences from library RPCI-11 for sequence-ready map building", XP002193666 * |
HONG C-J ET AL.: "Association analysis of the 5-HT6 receptor polymorphism (C267T) in mood disorders", AMERICAN JOURNAL OF MEDICAL GENETICS (NEUROPSYCHIATRIC GENETICS), vol. 88, 15 December 1999 (1999-12-15), pages 601 - 602, XP008001533 * |
KRUGLYAK L: "THE USE OF A GENETIC MAP OF BIALLELIC MARKERS IN LINKAGE STUDIES", NATURE GENETICS, NEW YORK, NY, US, vol. 17, 1997, pages 21 - 24, XP000920766, ISSN: 1061-4036 * |
SHINKAI T ET AL.: "Association study of the 5-HT6 receptor gene in Schizophrenia", AMERICAN JOURNAL OF MEDICAL GENETICS (NEUROPSYCHIATRIC GENETICS), vol. 88, 16 April 1999 (1999-04-16), pages 120 - 122, XP008001467 * |
SYVÄNEN A-CH ET AL: "IDENTIFICATION OF INDIVIDUALS BY ANALYSIS OF BIALLELIC DNA MARKERS,USING PCR AND SOLID-PHASE MINISEQUENCING", AMERICAN JOURNAL OF HUMAN GENETICS, UNIVERSITY OF CHICAGO PRESS, CHICAGO,, US, vol. 52, no. 1, 1993, pages 46 - 59, XP002050638, ISSN: 0002-9297 * |
TSAI S-J ET AL.: "Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease", NEUROSCIENCE LETTERS, vol. 276, 1999, pages 138 - 139, XP001066217 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001051659A2 (en) | 2001-07-19 |
CA2395240A1 (en) | 2001-07-19 |
EP1285088A2 (en) | 2003-02-26 |
AU2699901A (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000047771A3 (en) | Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism | |
WO1999032644A3 (en) | Prostate cancer gene | |
WO2001051659A3 (en) | Biallelic markers derived from genomic regions carrying genes involved in central nervous system disorders | |
WO2000047772A3 (en) | Polymorphic markers of the lsr gene | |
WO1999054500A3 (en) | Biallelic markers for use in constructing a high density disequilibrium map of the human genome | |
WO2001066800A3 (en) | Human single nucleotide polymorphisms | |
WO2000058508A3 (en) | Biallelic markers related to genes involved in drug metabolism | |
CA2348828A1 (en) | Genomic and complete cdna sequences of apm1 and biallelic markers thereof | |
WO2002006525A3 (en) | Obesity associated biallelic marker maps | |
WO2004081191A3 (en) | Molecular haplotyping of genomic dna | |
WO2000058519A3 (en) | Charaterization of single nucleotide polymorphisms in coding regions of human genes | |
WO2001042511A3 (en) | Ibd-related polymorphisms | |
WO2003042226A3 (en) | Single nucleotide polymorphisms in gh-1 | |
WO2001038576A3 (en) | Human single nucleotide polymorphisms | |
CA2289961A1 (en) | A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis | |
WO2002026764A3 (en) | Haplotypes of the ccr6 gene | |
WO2003054224A3 (en) | Method and integrated device for the detection of cytosine methylations | |
WO2002032928A3 (en) | Haplotypes of the hrh1 gene | |
WO2002026766A3 (en) | Haplotypes of the sstr4 gene | |
WO2001079231A3 (en) | Haplotypes of the npr1 gene | |
Szantai et al. | Haplotyping of the deoxycytidine kinase gene by multicapillary electrophoresis | |
WO2002016399A3 (en) | Haplotypes of the tacr1 gene | |
WO2002022650A3 (en) | Haplotypes of the per1 gene | |
WO2002053734A3 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
WO2001074833A3 (en) | Haplotypes of the chrnb2 gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 26999/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001901330 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2395240 Country of ref document: CA |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001901330 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |